Drug counterfeiting is a significant public health threat in Africa and other developing countries. This is a big problem for drug companies — and an even bigger problem for patients, whose lives may depend on these medications.
But technology can be a powerful asset in the fight against counterfeiting. And the good news is Sproxil and IBM are showing the way.
Click on the image below to open the slideshow version.